Sepiapterin, an essential cofactor of NOS, has been reported to improve gastric accommodation, but not symptoms, in women with diabetic gastroparesis [78]
This medication supports weight loss by targeting GLP-1 receptors
Retatrutide is a novel triple receptor agonist developed by Eli Lilly and Company that supports weight loss, improves glycemic control and also provides cardiovascular benefits
Insurance coverage for weight loss drugs varies based on the specific plan and the medical necessity of the therapy
This is a hormone that your body makes in your gut to tell your brain that youre full and its time to stop eating
If there were only one number to gauge your overall health, fitness, and longevity, it would be